A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 37 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Women diagnosed with tubal infertility, unexplained infertility, infertility related to endometriosis stage I/II or with partners diagnosed with male factor infertility
Women eligible for IVF (in-vitro fertilisation) and/or ICSI (intracytoplasmic sperm injection) treatment
Women aged 18-37 years
Women with body mass index (BMI) of 18.5-32.0 kg/m2
Women with polycystic ovary syndrome (PCOS) associated with anovulation, endometriosis stage III/IV
Women with history of recurrent miscarriage
Women with contraindications to controlled ovarian stimulation with gonadotropins
Women with three or more controlled ovarian stimulation cycles